biotech
EU Regulators Approve Generic Growth Hormone Omnitrope
Filed in archive Drugs, Vaccines and Therapeutics by ruth on January 29, 2006
BlogPicture

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) gave a positive opinion on the generic growth hormone Omnitrope, bringing the first so-called "biosimilar" drug one step closer to approval in Europe.

Omnitrope is a cheaper version of a branded drug intended for the treatment of growth disturbance and growth hormone Deficiency in children and adults. It is recombinant-DNA derived, and being a biosimilar is the first biosimilar to be given backing by the EU panel

Omnitrope is already approved in Australia, but in the US, its approval from the FDA is still pending, and due to the delay, Sandoz has filed a lawsuit in Sept 2005.

Read full story from Reuters.

Permalink: EU Regulators Approve Generic Growth Hormone Omnitrope
Tags: biosimilar  growth  biotech  hormone  omnitrope  growth+hormone  generic+growth  hormone+omnitrope 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/14593
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for EU Regulators Approve Generic Growth Hormone Omnitrope:

  • Currently 6.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.00 out of 4 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!